NANETS Webinar Series:
Hereditary Syndromes with NETs: MEN1/2, VHL Pheochromocytoma /Paraganglioma

September 16, 2020 – September 16, 2021

Members login HERE to view the recording



Lauren Fishbein, MD, PhD, University of Colorado School of Medicine
Mark Lewis, MD, Intermountain Healthcare

Learning Objectives:

  • Analyze the strengths and weaknesses of imaging modalities in identifying NETs
  • Recognize the relationships between genetics, immunochemistry and NETs. Identify the goals and role of surgery in the treatment and management of NETs
  • Examine the various symptom and medical management therapies of NETs
  • Illustrate the challenges in diagnosing and managing NETs
  • Apply a multidisciplinary approach to the management of NETs


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and North American Neuroendocrine Tumor Society. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.

The CMEsolutions designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component and 60% passing on MOC test, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.